ProfileGDS4095 / 230520_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 61% 62% 63% 65% 63% 64% 66% 65% 63% 65% 65% 65% 65% 65% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep14.9512161
GSM709769LY2 SRC1-siRNA tamoxifen treated rep35.1527562
GSM709765LY2 SRC1-siRNA untreated rep35.2967763
GSM709771LY2 SRC1-siRNA untreated rep15.6582965
GSM709772LY2 SRC1-siRNA untreated rep25.3541663
GSM709775LY2 SRC1-siRNA untreated rep45.4547164
GSM709764LY2 control-siRNA tamoxifen treated rep25.846866
GSM709766LY2 control-siRNA tamoxifen treated rep35.6378265
GSM709768LY2 control-siRNA tamoxifen treated rep15.4178863
GSM709777LY2 control-siRNA tamoxifen treated rep45.656665
GSM709770LY2 control-siRNA untreated rep35.8501765
GSM709773LY2 control-siRNA untreated rep15.7590865
GSM709774LY2 control-siRNA untreated rep25.7026865
GSM709776LY2 control-siRNA untreated rep45.730365